Immunic Inc (IMUX) — Cash Flow-to-Debt Ratio

Latest as of December 2025: -0.63x

Immunic Inc (IMUX) has a Cash Flow-to-Debt Ratio of -0.63x as of December 2025, meaning its operating cash flow of $-19.28 Million could theoretically repay -1% of its total liabilities ($30.73 Million) in one year. See IMUX free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.

CF-to-Debt Ratio

-0.63x
Operating CF / Total Liabilities

Operating Cash Flow

$-19.28 Million
USD

Total Liabilities

$30.73 Million
USD

Data as of

Dec 2025
Most recent filing

Immunic Inc Cash Flow-to-Debt Ratio (2011–2025)

Historical debt coverage capacity for Immunic Inc across 15 annual periods. For the full cash flow conversion analysis, see Immunic Inc (IMUX) cash conversion ratio.

Annual Cash Flow-to-Debt Ratio for Immunic Inc (2011–2025)

Year-by-year debt coverage analysis for Immunic Inc.

Year CF-to-Debt Ratio Operating CF (USD) Total Liabilities YoY Change
2025 -2.79x $-85.81 Million $30.73 Million ▲ +26.1%
2024 -3.78x $-84.77 Million $22.44 Million ▼ -35.3%
2023 -2.79x $-70.83 Million $25.37 Million ▲ +39.7%
2022 -4.63x $-65.14 Million $14.07 Million ▲ +33.3%
2021 -6.94x $-83.23 Million $11.98 Million ▼ -36.7%
2020 -5.08x $-46.12 Million $9.08 Million ▼ -35.2%
2019 -3.76x $-28.55 Million $7.59 Million ▲ +77.8%
2018 -16.92x $-43.16 Million $2.55 Million ▼ -333.1%
2017 -3.91x $-40.40 Million $10.34 Million ▲ +39.1%
2016 -6.41x $-35.77 Million $5.58 Million ▲ +13.3%
2015 -7.39x $-49.95 Million $6.76 Million ▼ -90.5%
2014 -3.88x $-40.83 Million $10.52 Million ▲ +30.0%
2013 -5.54x $-28.65 Million $5.17 Million ▼ -1577.2%
2012 -0.33x $-9.24 Million $27.96 Million ▼ -139.9%
2011 -0.14x $-7.83 Million $56.84 Million —
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.